HCE‐T cell‐based permeability model: A well‐maintained or a highly variable barrier phenotype?

[1]  Stephan Reichl,et al.  Cytochrome P450 Activity in Ex Vivo Cornea Models and a Human Cornea Construct. , 2016, Journal of pharmaceutical sciences.

[2]  Stephan Reichl,et al.  Expression of glutathione transferases in corneal cell lines, corneal tissues and a human cornea construct. , 2016, International journal of pharmaceutics.

[3]  J. Lovrić,et al.  Evaluation of cationic nanosystems with melatonin using an eye-related bioavailability prediction model. , 2015, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[4]  R Krull,et al.  Cellular uptake of coumarin-6 under microfluidic conditions into HCE-T cells from nanoscale formulations. , 2015, Molecular pharmaceutics.

[5]  P. Govoni,et al.  Development of a convenient ex vivo model for the study of the transcorneal permeation of drugs: histological and permeability evaluation. , 2015, Journal of pharmaceutical sciences.

[6]  K. Baumann,et al.  Recent progress in tight junction modulation for improving bioavailability , 2014, Expert opinion on drug discovery.

[7]  Stephan Reichl,et al.  Multidrug resistance-associated protein (MRP1, 2, 4 and 5) expression in human corneal cell culture models and animal corneal tissue. , 2014, Molecular pharmaceutics.

[8]  Stephan Reichl,et al.  Toward the practical implementation of eye-related bioavailability prediction models. , 2014, Drug discovery today.

[9]  James M. Anderson,et al.  Epithelial barrier assembly requires coordinated activity of multiple domains of the tight junction protein ZO-1 , 2013, Journal of Cell Science.

[10]  Stephan Reichl,et al.  Expression analysis of MDR1, BCRP and MRP3 transporter proteins in different in vitro and ex vivo cornea models for drug absorption studies. , 2013, International journal of pharmaceutics.

[11]  L. Zentilin,et al.  Terminal differentiation of cardiac and skeletal myocytes induces permissivity to AAV transduction by relieving inhibition imposed by DNA damage response proteins. , 2012, Molecular therapy : the journal of the American Society of Gene Therapy.

[12]  Stephan Reichl,et al.  Prevalidation of a human cornea construct as an alternative to animal corneas for in vitro drug absorption studies. , 2012, Journal of pharmaceutical sciences.

[13]  S. Reichl,et al.  mRNA expression of metabolic enzymes in human cornea, corneal cell lines, and hemicornea constructs. , 2012, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[14]  T. Takezawa,et al.  Development of a human corneal epithelium model utilizing a collagen vitrigel membrane and the changes of its barrier function induced by exposing eye irritant chemicals. , 2011, Toxicology in vitro : an international journal published in association with BIBRA.

[15]  Fabian Müller,et al.  Influence of Non-Steroidal Anti-Inflammatory Drugs on Organic Anion Transporting Polypeptide (OATP) 1B1- and OATP1B3-Mediated Drug Transport , 2011, Drug Metabolism and Disposition.

[16]  Stephan Reichl,et al.  In vitro cell culture models to study the corneal drug absorption , 2011, Expert opinion on drug metabolism & toxicology.

[17]  Stephan Reichl,et al.  Development of a serum-free human cornea construct for in vitro drug absorption studies: the influence of varying cultivation parameters on barrier characteristics. , 2010, International journal of pharmaceutics.

[18]  E. D. Amo,et al.  Prediction of the Corneal Permeability of Drug-Like Compounds , 2010, Pharmaceutical Research.

[19]  M. Häkli,et al.  Effluxing ABC transporters in human corneal epithelium. , 2010, Journal of pharmaceutical sciences.

[20]  D. Barends,et al.  Biowaiver monographs for immediate release solid oral dosage forms: diclofenac sodium and diclofenac potassium. , 2009, Journal of pharmaceutical sciences.

[21]  C. Baudouin,et al.  Multiple endpoint analysis of the 3D-reconstituted corneal epithelium after treatment with benzalkonium chloride: early detection of toxic damage. , 2009, Investigative ophthalmology & visual science.

[22]  N. Nagai,et al.  Contribution of aldehyde dehydrogenase 3A1 to disulfiram penetration through monolayers consisting of cultured human corneal epithelial cells. , 2008, Biological & pharmaceutical bulletin.

[23]  Stephan Reichl,et al.  Cell culture models of the human cornea — a comparative evaluation of their usefulness to determine ocular drug absorption in‐vitro , 2008, The Journal of pharmacy and pharmacology.

[24]  C. Ehrhardt,et al.  A Comparative Evaluation of Corneal Epithelial Cell Cultures for Assessing Ocular Permeability , 2008, Alternatives to laboratory animals : ATLA.

[25]  K. Ward,et al.  Use of a Human Corneal Epithelial Cell Line for Screening the Safety of Contact Lens Care Solutions In Vitro , 2008, Eye & contact lens.

[26]  P. Artursson,et al.  Determination of drug permeability and prediction of drug absorption in Caco-2 monolayers , 2007, Nature Protocols.

[27]  K. Ruprecht,et al.  Expression of ABC-transporters in human corneal tissue and the transformed cell line, HCE-T. , 2007, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[28]  Kati-Sisko Vellonen,et al.  Drug transport in corneal epithelium and blood-retina barrier: emerging role of transporters in ocular pharmacokinetics. , 2006, Advanced drug delivery reviews.

[29]  S Reichl,et al.  Human corneal equivalent as cell culture model for in vitro drug permeation studies , 2004, British Journal of Ophthalmology.

[30]  E. Toropainen,et al.  Paracellular and passive transcellular permeability in immortalized human corneal epithelial cell culture model. , 2003, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[31]  N. Koizumi,et al.  Comparison of ultrastructure, tight junction-related protein expression and barrier function of human corneal epithelial cells cultivated on amniotic membrane with and without air-lifting. , 2003, Experimental eye research.

[32]  A. Urtti,et al.  Culture model of human corneal epithelium for prediction of ocular drug absorption. , 2001, Investigative ophthalmology & visual science.

[33]  E. Solary,et al.  Effects of cyclosporin at various concentrations on dexamethasone intracellular uptake in multidrug resistant cells , 2000, Annals of the rheumatic diseases.

[34]  T. Imai,et al.  Effects of absorption enhancers on the transport of model compounds in Caco-2 cell monolayers: assessment by confocal laser scanning microscopy. , 1997, Journal of pharmaceutical sciences.

[35]  C. Fry,et al.  Membrane action of chloramphenicol measured by protozoan motility inhibition , 1996, Archives of Toxicology.

[36]  M. Kubista,et al.  Absorption and fluorescence properties of fluorescein , 1995 .

[37]  H. Handa,et al.  An SV40-immortalized human corneal epithelial cell line and its characterization. , 1995, Investigative ophthalmology & visual science.

[38]  Tucker Sp,et al.  Migration of polarized epithelial cells through permeable membrane substrates of defined pore size. , 1992 .

[39]  R. Compans,et al.  Migration of polarized epithelial cells through permeable membrane substrates of defined pore size. , 1992, European journal of cell biology.

[40]  A. Chiarini,et al.  pH‐Solubility Relationship and Partition Coefficients for some Anti‐Inflammatory Arylaliphatic Acids , 1984 .